Simbec-Orion Receives The “CRO Of The Year” Award At 2019 European Lifestars AwardsTM

Simbec-Orion Receives The “CRO Of The Year” Award At 2019 European Lifestars AwardsTM

Celebrating success across life sciences

London, UK, November 25th 2019. Simbec-Orion is pleased to announce that it has been recognised as the winner of the CRO of the Year award at the 2019 Lifestars AwardsTM.

Lifestars is a celebration of the success stories, innovations, transformational deals and the people, teams and organisations that play such a critical role in the advancement of the industry over the last 12 months across Europe.

The international awards bring together hundreds of global life science leaders, investors and deal makers and key stakeholders from the wider eco-system to recognise the achievements of the industry. 19 awards were contested during a prestigious gala dinner hosted at the Honourable Artillery Company in London, UK on the 19th November. The Awards supported Teenage Cancer Trust as the official Charity beneficiary.

European Lifestars AwardsTM forms a signature, evening networking function during the Investival Showcase and Jefferies Annual Healthcare Conference week in London, Europe’s largest healthcare investment banking conference.

“I am absolutely honoured to accept this award on behalf of Simbec-Orion and to share it with our amazing team of clinical research professionals,” Dr Fabrice Chartier, recently appointed CEO.

“This award acknowledges the commitment we have made to structure our business to meet the needs of small and mid and size drug developers, developing new therapies in rare disease and oncology.

This accolade recognizes the breadth of our full-service, which includes a dedicated clinical pharmacology group, clinical development focused on rare disease and oncology, and our laboratory services. When combined with our expertise gained from working in translational medicine and challenging therapeutic areas, we can ally with clients in the most cost-effective and flexible approach, to reach their clinical and commercial milestones’. Dr Fabrice Chartier CEO, Simbec-Orion

“Lifestars presents a fantastic opportunity to bring together a deserved audience and highlight the advances being made in our industry. It’s testament to Simbec-Orion’s efforts that this year’s judging faculty have recognized them in this manner.” Neil Darkes, Co-CEO, LSX Ltd. and Lifestars